Literature DB >> 2842104

Interactions among stimulated human polymorphonuclear leucocytes, released elastase and bronchial antileucoprotease.

J A Kramps1, C van Twisk, E C Klasen, J H Dijkman.   

Abstract

1. We investigated the effect of stimulated human polymorphonuclear leucocytes (PMN's) on both the antitrypsin and anti-elastase activity of bronchial antileucoprotease (ALP). 2. Incubation of ALP with stimulated human PMN's resulted in a rapid loss of anti-elastase activity which paralleled that of the antitrypsin activity, suggesting that both inhibitor activities are represented by the same active site. 3. The myeloperoxidase-oxidizing system was found to be responsible for the inactivation of ALP. 4. The oxidized inhibitor was unable to form stable complexes with PMN elastase but was resistant to breakdown by proteolytic enzymes from stimulated PMN's. 5. It was observed that stimulated cells are capable of releasing elastase which shows full activity in the presence of a large molar excess of ALP. 6. We conclude from this study that stimulated PMN's are able to inactivate ALP by which released elastase is able to express enzymatic activity in spite of the presence of this low-molecular-weight inhibitor. Thus, inactivation of ALP by triggered PMN's may contribute to destructive processes in which elastase is thought to be a mediator.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842104     DOI: 10.1042/cs0750053

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  Plasma leucocyte elastase concentrations in smokers.

Authors:  C R Hind; H Joyce; G A Tennent; M B Pepys; N B Pride
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 2.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

4.  Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Authors:  C Vogelmeier; R C Hubbard; G A Fells; H P Schnebli; R C Thompson; H Fritz; R G Crystal
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

5.  Detection of extracellular neutrophil elastase in hamster lungs after intratracheal instillation of E. coli lipopolysaccharide using a fluorogenic, elastase-specific, synthetic substrate.

Authors:  A Rudolphus; J Stolk; C van Twisk; C J van Noorden; J H Dijkman; J A Kramps
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.

Authors:  M M Bridgeman; M Marsden; W MacNee; D C Flenley; A P Ryle
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

7.  In vivo suppression of immune complex-induced alveolitis by secretory leukoproteinase inhibitor and tissue inhibitor of metalloproteinases 2.

Authors:  M S Mulligan; P E Desrochers; A M Chinnaiyan; D F Gibbs; J Varani; K J Johnson; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

8.  Antiproteases modulate bronchial epithelial cell responses to endotoxin.

Authors:  S Koyama; S I Rennard; L Claassen; R A Robbins
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

9.  Neutrophil-derived Oxidants and Proteinases as Immunomodulatory Mediators in Inflammation.

Authors:  V Witko-Sarsat; B Descamps-Latscha
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

10.  Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases.

Authors:  C A Owen; M A Campbell; P L Sannes; S S Boukedes; E J Campbell
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.